Study With TMX-101 in Patients With Carcinoma In Situ (CIS) Bladder Cancer
Status:
Completed
Trial end date:
2014-10-01
Target enrollment:
Participant gender:
Summary
This is a Phase II pilot study to explore the effect of intravesical TMX-101 in patients with
CIS bladder cancer, as assessed by histology and cytology after TMX-101 treatment.